Methotrexate and histologic hepatic abnormalities: A meta-analysis
- 1 January 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 90 (1) , 711-716
- https://doi.org/10.1016/0002-9343(91)90667-m
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Histopathologic findings in the liver of rheumatoid arthritis patients treated with long‐term bolus methotrexateArthritis & Rheumatism, 1988
- Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- Magnetic resonance imaging as a screening procedure for methotrexate induced liver damageBritish Journal of Dermatology, 1987
- Hepatotoxicity Associated with Low-dose, Long-term Methotrexate Treatment of Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1987
- Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritisCleveland Clinic Journal of Medicine, 1985
- Methotrexate therapy in rheumatoid arthritis: 15 years experienceThe American Journal of Medicine, 1983
- Methotrexate Hepatotoxicity in PsoriasisArchives of Dermatology, 1980
- Hepatotoxic effects of methotrexateCancer, 1966
- Methotrexate for Psoriasis: A Preliminary ReportCleveland Clinic Journal of Medicine, 1965
- THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITYThe Lancet Healthy Longevity, 1951